Formulation Approaches and Strategies for Vaccines and Adjuvants
作者： Kimberly J. Hassett , Pradyot Nandi , Theodore W. Randolph
DOI: 10.1007/978-1-4614-7978-9_6
关键词:
摘要: In order to create safe and efficacious vaccines, formulations that confer stability must generally be developed. this chapter, formulation considerations consisting of solution conditions, particles, delivery route, endotoxin level, preservatives will covered along with the addition adjuvants currently approved for use in vaccines being researched. Methods increase vaccine analytical techniques used monitor discussed.
springer.com
sci-hub.se 参考文章(98)
David B. Volkin, Gautam Sanyal, Carl J. Burke, C. Russell Middaugh, Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals. Pharmaceutical biotechnology. ,vol. 14, pp. 1- 46 ,(2002) , 10.1007/978-1-4615-0549-5_1
Development and manufacture of protein pharmaceuticals Kluwer Academic/Plenum Publishers. ,(2002) , 10.1007/978-1-4615-0549-5
John F. Carpenter, Michael J. Pikal, Byeong S. Chang, Theodore W. Randolph, Rational design of stable lyophilized protein formulations: some practical advice. Pharmaceutical Research. ,vol. 14, pp. 969- 975 ,(1997) , 10.1023/A:1012180707283
Byeong S. Chang, Susan Hershenson, Practical approaches to protein formulation development. Pharmaceutical biotechnology. ,vol. 13, pp. 1- 25 ,(2002) , 10.1007/978-1-4615-0557-0_1
Mark C. Manning, Kamlesh Patel, Ronald T. Borchardt, Stability of Protein Pharmaceuticals Pharmaceutical Research. ,vol. 6, pp. 903- 918 ,(1989) , 10.1023/A:1015929109894
Michael J. Akers, Vasu Vasudevan, Mary Stickelmeyer, Formulation development of protein dosage forms. Pharmaceutical biotechnology. ,vol. 14, pp. 47- 127 ,(2002) , 10.1007/978-1-4615-0549-5_2
Paul J Sheskey, Marian E Quinn, Raymond C Rowe, Handbook of Pharmaceutical Excipients ,(1994)
Adluri S, Oettgen Hf, Livingston Po, Calves M, Shang A, Helling F, Yao Tj, Zhang S, Koganty R, Longenecker Bm, GM2-KLH Conjugate Vaccine: Increased Immunogenicity in Melanoma Patients after Administration with Immunological Adjuvant QS-21 Cancer Research. ,vol. 55, pp. 2783- 2788 ,(1995)
D Marciani, U Patel, M Lennick, C R Kensil, Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. Journal of Immunology. ,vol. 146, pp. 431- 437 ,(1991)
E.E Worrall, J.K Litamoi, B.M Seck, G Ayelet, Xerovac: an ultra rapid method for the dehydration and preservation of live attenuated Rinderpest and Peste des Petits ruminants vaccines. Vaccine. ,vol. 19, pp. 834- 839 ,(2000) , 10.1016/S0264-410X(00)00229-2